Stay updated with breaking news from 02343610. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com upgraded shares of Amedisys (NASDAQ:AMED – Free Report) from a hold rating to a buy rating in a report published on Saturday morning. A number of other equities research analysts have also weighed in on the stock. Cantor Fitzgerald reiterated a neutral rating and set a $101.00 target price on shares of Amedisys in […]
Cantor Fitzgerald restated their neutral rating on shares of Amedisys (NASDAQ:AMED – Free Report) in a report released on Thursday morning, Benzinga reports. The firm currently has a $101.00 price objective on the health services provider’s stock. Several other equities research analysts have also commented on the stock. StockNews.com started coverage on shares of Amedisys […]
Amedisys (NASDAQ:AMED – Get Free Report) released its quarterly earnings results on Wednesday. The health services provider reported $1.03 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01, Briefing.com reports. The firm had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys […]
Amedisys (NASDAQ:AMED – Get Free Report) issued its earnings results on Wednesday. The health services provider reported $1.03 earnings per share for the quarter, beating the consensus estimate of $1.02 by $0.01, Briefing.com reports. The business had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. Amedisys had a […]
Amedisys (NASDAQ:AMED – Get Free Report) announced its earnings results on Wednesday. The health services provider reported $1.03 EPS for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01, Briefing.com reports. The company had revenue of $571.41 million for the quarter, compared to analysts’ expectations of $565.38 million. Amedisys had a positive return on […]